Page last updated: 2024-10-27

gentamicin and Acantholysis Bullosa

gentamicin has been researched along with Acantholysis Bullosa in 2 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bolling, MC1
Has, C1
Bruckner, AL1
Vishwanath, T1
Agrawal, S1
Ghate, S1
Shinde, G1
Gala, P1
Ingle, K1

Other Studies

2 other studies available for gentamicin and Acantholysis Bullosa

ArticleYear
Understanding the Potential Promise and Pitfalls of Intravenous Gentamicin as a Therapy for Epidermolysis Bullosa.
    JAMA dermatology, 2022, 04-01, Volume: 158, Issue:4

    Topics: Administration, Intravenous; Epidermolysis Bullosa; Gentamicins; Humans; Wound Healing

2022
Intrabullous injection: A novel, painless technique of drug delivery in localized bullous dermatoses.
    Journal of the American Academy of Dermatology, 2019, Volume: 81, Issue:6

    Topics: Drug Delivery Systems; Epidermolysis Bullosa; Female; Gentamicins; Humans; Injections, Intralesional

2019